-transparent.png){kind=logo}
Blood Cys concentrations were monitored twice weekly by RIA in nine patients undergoing renal transplantation. The Cys dose was adapted to obtain blood values between 100-400ng/ml. A negative correlation was found between plasma creatinine and blood Cys, even in those patients in whom the oral dosage was not changed (r = 0.65, n = 23, p less than 0.001). In vitro studies showed no effect of uraemic blood on Cys measurement. It seems probable that uraemia induces changes in distribution volume and/or gastrointestinal absorption of the drug. Careful monitoring of Cys during uraemia is therefore warranted.
Related Publications
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
January 1985,
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
January 1996,
The Annals of pharmacotherapy,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
February 1986,
Transplantation,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
October 2010,
Therapeutic drug monitoring,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
December 2000,
Transplantation proceedings,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
October 1994,
Transplantation proceedings,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
January 2002,
Annals of clinical biochemistry,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
February 1992,
Prostaglandins, leukotrienes, and essential fatty acids,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
November 1983,
Clinical pharmacology and therapeutics,
M Burnier, and
P Aebischer, and
J P Wauters, and
J L Schelling
April 2000,
The New England journal of medicine,
